Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0001062993-24-003168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-14 | 2024-02-12 | COLL | Smith Thomas B | EVP, Chief Medical Off | F - Tax | $33.70 | -3,199 | 65.7K | -5% | -$107.8K |
| M | 2024-02-14 | 2024-02-12 | COLL | Smith Thomas B | EVP, Chief Medical Off | A - Grant | $0.00 | +35.4K | 63.0K | +129% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | F | D | 1,300 | $33.70 | 64,404 | D | — | — | (F5) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs. |
| 2 | Common | Common Stock | 2024-02-12 | F | D | 1,899 | $33.70 | 65,704 | D | — | — | (F4) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs. |
| 3 | Common | Common Stock | 2024-02-12 | A | A | 4,623 | $0.00 | 67,603 | D | — | — | (F3) Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 4,623 performance share units ("PSUs") granted in the Issuer's prior fiscal year. |
| 4 | Common | Common Stock | 2024-02-12 | A | A | 30,800 | $0.00 | 62,980 | D | — | — | (F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. (F2) Includes 442 and 553 shares acquired on each of July 21, 2023 and January 19, 2024, respectively, under the Issuer's employee stock purchase plan. |